Amedisys Announces Retirement of Board Member Linda J. Hall
February 19 2019 - 7:30AM
Amedisys, Inc. (NASDAQ: AMED), America’s leading independent home
health, hospice and personal care company, announced today that Ms.
Linda J. Hall, Ph.D., will retire from its Board of Directors.
After more than six years of distinguished and invaluable service,
Ms. Hall will retire on June 7, 2019, at the expiration of her
current board term, but will continue to be available to Amedisys
for a year following her retirement under a consulting agreement.
“Linda’s significant management experience in the healthcare
industry and substantial public-company board experience made her a
tremendous asset to our Board,” stated Don Washburn, Non-Executive
Chairman of the Board. “We extend our gratitude and best wishes to
Linda and her family.”
Ms. Hall joined the Board of Directors on March 6, 2013 and has
chaired the Compliance and Ethics Committee since the committee's
inception in October 2013. She also serves as a member of the
Quality of Care and Nominating & Corporate Governance
Committees. During her tenure, Ms. Hall has provided continuity of
leadership to the Compliance and Ethics Committee through a
complete change in executive leadership at Amedisys, helping to
navigate the Corporate Integrity Agreement entered into in 2014 and
which Amedisys expects to successfully complete in April of this
year; served as a strong advocate for the Compliance Department,
supported its transformation from a corporate-based to a strong
field-based compliance team; and was committed to the company
delivering the highest quality of care in the industry. “Linda’s
contributions to Amedisys are many and I am extremely grateful for
her leadership and dedication; especially in the area of
compliance,” stated Paul Kusserow, Amedisys CEO and Member of the
Board. “She insisted on the highest of standards
and helped Amedisys build our culture of compliance which is now an
integral part of who we are.” “Linda has been a stalwart
supporter of the Compliance team since she first arrived on the
Board of Directors,” stated Amedisys Chief Compliance Officer David
Pearce. “As chair of the Compliance Committee, her unique
combination of intelligence and perceptiveness made her extremely
effective at identifying the compliance risks facing the company
and helping to mitigate them. Both I and the company owe Linda a
huge debt of gratitude for her service. She will be missed on the
Committee, but she leaves a modernized and improved compliance
function as her legacy.”
Media Contact: |
Investor Contact: |
|
|
Kendra Kimmons |
Nick Muscato |
Vice President of Marketing &
Communications |
Vice President of Strategic Finance |
225-299-3708 |
615-928-5452 |
kendra.kimmons@amedisys.com |
nick.muscato@amedisys.com |
Forward-Looking Statements:When included in
this press release, words like “believes,” “belief,” “expects,”
“plans,” “anticipates,” “intends,” “projects,” “estimates,” “may,”
“might,” “would,” “should,” “will” and similar expressions are
intended to identify forward-looking statements as defined by the
Private Securities Litigation Reform Act of 1995. These
forward-looking statements include, but are not limited to,
statements regarding the expected completion of our corporate
integrity agreement. These forward-looking statements involve a
variety of risks and uncertainties that could cause actual results
to differ materially from those described therein. These risks and
uncertainties include, but are not limited to the following: our
ability to comply with requirements stipulated in our corporate
integrity agreement, changes in or our failure to comply with
existing federal and state laws or regulations or the inability to
comply with new government regulations on a timely basis, changes
in Medicare and other medical payment levels, our ability to open
care centers, acquire additional care centers and integrate and
operate these care centers effectively, competition in the
healthcare industry, changes in the case mix of patients and
payment methodologies, changes in estimates and judgments
associated with critical accounting policies, our ability to
maintain or establish new patient referral sources, our ability to
attract and retain qualified personnel, changes in payments and
covered services by federal and state governments, future cost
containment initiatives undertaken by third-party payors, our
access to financing, our ability to meet debt service requirements
and comply with covenants in debt agreements, business disruptions
due to natural disasters or acts of terrorism, our ability to
integrate, manage and keep our information systems secure, our
ability to realize the anticipated benefits of the acquisition of
Compassionate Care Hospice, and changes in law or
developments with respect to any litigation relating to the
Company, including various other matters, many of which are beyond
our control.
Because forward-looking statements are inherently subject to
risks and uncertainties, some of which cannot be predicted or
quantified, you should not rely on any forward-looking statement as
a prediction of future events. We expressly disclaim any obligation
or undertaking and we do not intend to release publicly any updates
or changes in our expectations concerning the forward-looking
statements or any changes in events, conditions or circumstances
upon which any forward-looking statement may be based, except as
required by law.
About Amedisys: Amedisys, Inc. is a leading
healthcare at home Company delivering personalized home health,
hospice and personal care. Amedisys is focused on delivering the
care that is best for our patients, whether that is home-based
personal care; recovery and rehabilitation after an operation or
injury; care focused on empowering them to manage a chronic
disease; or hospice care at the end of life. More than 3,000
hospitals and 65,000 physicians nationwide have chosen Amedisys as
a partner in post-acute care. Founded in 1982, headquartered in
Baton Rouge, LA with an executive office in Nashville, TN, Amedisys
is a publicly held company. With more than 21,000 employees in 472
care centers in 38 states and the District of Columbia, Amedisys is
dedicated to delivering the highest quality of care to the
doorsteps of more than 376,000 patients and clients in need every
year. For more information about the Company, please
visit: www.amedisys.com.
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Apr 2023 to Apr 2024